| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |